021-51111890
购物车（）
sales@molnova.cn
DATPT
CAS No. 2891582-75-3
DATPT ( —— )
产品货号. M36598 CAS No. 2891582-75-3
DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.DATPT has anti-inflammatory and antimicrobial activity and acts by decreasing ATP production.DATPT is a potential compound for the treatment of sepsis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2442 | 有现货 |
|
| 10MG | ￥3924 | 有现货 |
|
| 25MG | ￥6036 | 有现货 |
|
| 50MG | ￥8138 | 有现货 |
|
| 100MG | ￥10620 | 有现货 |
|
| 200MG | ￥14310 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称DATPT
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.DATPT has anti-inflammatory and antimicrobial activity and acts by decreasing ATP production.DATPT is a potential compound for the treatment of sepsis.
-
产品描述DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.DATPT has anti-inflammatory and antimicrobial activity and acts by decreasing ATP production.DATPT is a potential compound for the treatment of sepsis.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Reactive Oxygen Species | Antibacterial
-
研究领域——
-
适应症——
化学信息
-
CAS Number2891582-75-3
-
分子量495.06
-
分子式C24H39ClN6O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.N=1C(=NC(=NC1NCC2OCCC2)C=3C=CC(=CC3)C(C)(C)C)NCCOCCOCCN
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Neuropeptide Y (3-36...
Neuropeptide Y (3-36) (human, rat) 是由二肽基肽酶4 (DPP4) 形成的神经肽Y (NPY) 代谢产物，是一种选择性 Y2 受体激动剂。Neuropeptide Y (3-36) (human, rat) 是由二肽基肽酶 4 (DPP4) 形成的 NPY 代谢产物。Neuropeptide Y (3-36) (human, rat) 通过 Y2 受体减少去甲肾上腺素的释放。
-
(+)-Fargesin
(+)-Fargesin
-
Itolizumab
Itolizumab (Anti-Human CD6 Recombinant Antibody) 是一种人源化重组 抗 CD6 单克隆抗体 (MAb)，靶向 CD6 的细胞外 SRCR 远端结构域 1。Itolizumab 可减少 T 细胞增殖并抑制促炎细胞因子的产生，例如 INF-γ、TNFα 和 IL-6。Itolizumab 可用于银屑病、类风湿性关节炎 (RA)、COVID-19 的研究。
